Log in to save to my catalogue

Orexin (Hypocretin) Receptor Agonists and Antagonists for Treatment of Sleep Disorders: Rationale fo...

Orexin (Hypocretin) Receptor Agonists and Antagonists for Treatment of Sleep Disorders: Rationale fo...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1560136944

Orexin (Hypocretin) Receptor Agonists and Antagonists for Treatment of Sleep Disorders: Rationale for Development and Current Status

About this item

Full title

Orexin (Hypocretin) Receptor Agonists and Antagonists for Treatment of Sleep Disorders: Rationale for Development and Current Status

Publisher

Cham: Springer International Publishing AG

Journal title

CNS drugs, 2013-02, Vol.27 (2), p.83-90

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing AG

More information

Scope and Contents

Contents

Orexin A and orexin B are hypothalamic neuropeptides initially identified as endogenous ligands for two orphan G-protein coupled receptors (GPCRs). They play critical roles in the maintenance of wakefulness by regulating function of monoaminergic and cholinergic neurons that are implicated in the regulation of wakefulness. Loss of orexin neurons in...

Alternative Titles

Full title

Orexin (Hypocretin) Receptor Agonists and Antagonists for Treatment of Sleep Disorders: Rationale for Development and Current Status

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1560136944

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1560136944

Other Identifiers

ISSN

1172-7047

E-ISSN

1179-1934

DOI

10.1007/s40263-012-0036-8

How to access this item